REGN

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions.

Regeneron Pharmaceuticals, Inc. (REGN) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $591.52 and $935.35, and it pays a dividend every quarter.

• Healthcare
• Biotechnology
• Tarrytown, United States
• 15.4K employees
• Led by Leonard S. Schleifer M.D., Ph.D.